{
    "id": "dbpedia_8905_3",
    "rank": 52,
    "data": {
        "url": "https://www.aasld.org/practice-guidelines/clinical-assessment-and-management-metabolic-dysfunction-associated-steatotic",
        "read_more_link": "",
        "language": "en",
        "title": "Clinical Assessment and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease",
        "top_image": "https://www.aasld.org/themes/custom/aasld_theme/favicon.ico",
        "meta_img": "https://www.aasld.org/themes/custom/aasld_theme/favicon.ico",
        "images": [
            "https://www.facebook.com/tr?id=385251799608255&ev=PageView&noscript=1",
            "https://www.aasld.org/themes/custom/aasld_theme/logo.svg",
            "https://www.aasld.org/themes/custom/aasld_theme/logo.svg",
            "https://www.aasld.org/sites/default/files/logo-aasld-white.svg"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "AASLD develops evidence-based practice guidelines and practice guidances which are updated regularly by a committee of hepatology experts and include recommendations of preferred approaches to the diagnostic, therapeutic, and preventive aspects of care.",
        "meta_lang": "en",
        "meta_favicon": "/themes/custom/aasld_theme/favicon.ico",
        "meta_site_name": "",
        "canonical_link": "https://www.aasld.org/practice-guidelines/clinical-assessment-and-management-metabolic-dysfunction-associated-steatotic",
        "text": "AASLD develops evidence-based practice guidelines and practice guidances which are updated regularly by a committee of hepatology experts and include recommendations of preferred approaches to the diagnostic, therapeutic, and preventive aspects of care.\n\nSupplemental Materials\n\nThis AACE guideline provides evidence-based recommendations regarding the diagnosis and management of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) to endocrinologists, primary care clinicians, health care professionals, and other stakeholders. It was co-sponsored by AASLD.\n\nDiagnosis and Management of Nonalcoholic Fatty Liver Disease Patient Guideline\n\nAmerican Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Setting [updated May 2022]"
    }
}